Hawaii Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 13 (93% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 3,833
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 88.98%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 762
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 95.15%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 9.26% 3.15%
White, Hispanic/Latino Patients 1.72% 1.05%
Black/African American, Non-Hispanic/Latino Patients 0.86% 0.52%
Black/African American, Hispanic/Latino Patients 0.10% 0.00%
Asian Patients3 14.58% 11.15%
American Indian/Alaska Native Patients3 0.44% 0.26%
Native Hawaiian/Other Pacific Islander Patients3 51.11% 45.01%
Patients with More than one race3 5.53% 3.67%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.44% 0.13%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.43% 0.92%
Unreported/Refused to Report Race and Ethnicity 14.51% 34.12%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 1,437
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 91.83%
COVID-19 Immunization Series Completed 1,655
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 88.99%
COVID-19 Immunization Series Additional 129
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 68.57%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 6.61% 9.18% 25.58%
White, Hispanic/Latino Patients 0.90% 1.69% 1.55%
Black/African American, Non-Hispanic/Latino Patients 0.63% 0.79% 1.55%
Black/African American, Hispanic/Latino Patients 0.21% 0.00% 0.00%
Asian Patients3 10.72% 12.33% 22.48%
American Indian/Alaska Native Patients3 0.56% 0.48% 1.55%
Native Hawaiian/Other Pacific Islander Patients3 55.25% 51.72% 17.05%
Patients with More than one race3 4.66% 6.40% 4.65%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.39% 0.79% 6.98%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.18% 1.75% 1.55%
Unreported/Refused to Report Race and Ethnicity 17.88% 14.86% 17.05%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 0.00%
1 to 24 Hours 61.54%
More Than 24 Hours 30.77%
N/A 7.69%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 23.08%
Vaccine confidence 38.46%
Vaccine storage capacity 7.69%
Vaccine supply 0.00%
Other 23.08%
None 30.77%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 86.54%
Average Percent of Health Center Visits Conducted Virtually 24.23%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 46.15%
Number of Mobile Van Sites 0
Number of Pop-up Clinics 20
Number of School-Based Vaccination Sites 4

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 30.77%
Refer patients to another organization that provides monoclonal antibody therapies 23.08%
None 53.85%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 15.38%
Patient awareness/education 0.00%
Staffing capacity 15.38%
Therapy administration/onsite logistics 15.38%
Other 7.69%
None 46.15%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021